Marc Goodman

Work

Analyst Marc Goodman works at LEERINK and is focused on the Healthcare sector with 481 price targets and ratings documented since 2010 spanning on 34 stocks. Previously, Marc Goodman worked at UBS. Analyst's average stock valuation to be materialised ratio is 58.8% with an average time for price targets to be met of 243.97 days.

Most recent stock forecast was given on MRNS, at 23-Jan-2023.

Marc Goodman best performing recommendations are on SAGE (SAGE THERAPEUTICS, INC).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTICS, INC) at 12/4/2019. The price target of $63 was fulfilled within 1 day with a profit of $86.21 (57.78%) receiving and performance score of 577.78.

Average potential price target upside

ABBV ACAD AGN ALDX AXSM BHVN BMY GILD GMTX JAZZ LLY MNK MRK MYL NBIX PRGO REGN SAGE VRTX ZGNX ALKS HZNP APTX AVDL GRAY KRTX AMLX ELYM MRNS VTRS XENE ITCI STSA BIIB

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

157

$12.16 (8.40%)

155

20 days ago

33/34 (97.06%)

$24.49 (29.07%)

425

Buy

182

$37.16 (25.66%)

178

2 months ago

14/22 (63.64%)

$25.08 (28.76%)

561

Hold

140

$-4.84 (-3.34%)

172

2 months 29 days ago

0/2 (0%)

$25.87 (23.60%)

Hold

155

$10.16 (7.01%)

160

3 months 6 days ago

7/8 (87.5%)

$12.27 (10.71%)

76

Buy

169

$24.16 (16.68%)

174

3 months 6 days ago

11/13 (84.62%)

$16.17 (14.62%)

118

Show more analysts
ABBV ACAD AGN ALDX AXSM BHVN BMY GILD GMTX JAZZ LLY MNK MRK MYL NBIX PRGO REGN SAGE VRTX ZGNX ALKS HZNP APTX AVDL GRAY KRTX AMLX ELYM MRNS VTRS XENE ITCI STSA BIIB